Federated Hermes’s Odonate Therapeutics, Inc. Common Stock ODT Stock Holding History

Federated Hermes’s Portfolio ODT Stock Details ODT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-4,279	Closed	-$6K	–	2398
2021 Q4	$6K	Buy	4,279 +1,648	+63%	+$3.9K	﹤0.01%	1986
2021 Q3	$8K	Buy	2,631 +2,444	+1,307%	+$8.13K	﹤0.01%	2011
2021 Q2	$1K	Buy	+187	New	+$642	﹤0.01%	2185
2020 Q4	–	Sell	-58,766	Closed	-$789K	–	2387
2020 Q3	$789K	Buy	58,766 +34,591	+143%	+$980K	﹤0.01%	1336
2020 Q2	$1.02M	Buy	+24,175	New	+$782K	﹤0.01%	1238
2019 Q3	–	Sell	-1,052	Closed	-$39K	–	2322
2019 Q2	$39K	Sell	1,052 -1,848	-64%	-$44.3K	﹤0.01%	1712
2019 Q1	$64K	Sell	2,900 -264	-8%	-$4.62K	﹤0.01%	1634
2018 Q4	$45K	Sell	3,164 -343	-10%	-$5.34K	﹤0.01%	1672
2018 Q3	$68K	Buy	+3,507	New	+$71.5K	﹤0.01%	1705

Other funds holding ODT

Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

HWAM

Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Simplex Trading Chicago, Illinois $149B AUM 62.07% 1-Year Est. Return

Federated Hermes's ODT Position: Q1 2022 in Review

Federated Hermes sold out of Odonate Therapeutics, Inc. Common Stock (ODT) in Q1 2022, closing a stake of 4,279 shares — an estimated $6K sold.

Federated Hermes first reported a position in ODT in Q3 2018 and held it in 9 quarters. The position peaked at $1.02M in Q2 2020. 8 funds tracked by Wall St. Rank hold ODT as of Q1 2022.

Federated Hermes reported no remaining Odonate Therapeutics, Inc. Common Stock position as of Q1 2022 after selling out during the quarter.
Federated Hermes sold 4,279 Odonate Therapeutics, Inc. Common Stock shares in Q1 2022, an estimated $6K.
Federated Hermes first reported a position in Odonate Therapeutics, Inc. Common Stock in Q3 2018 and held it in 9 quarters.
Federated Hermes's Odonate Therapeutics, Inc. Common Stock position peaked at $1.02M in Q2 2020.
8 funds tracked by Wall St. Rank held Odonate Therapeutics, Inc. Common Stock as of Q1 2022.

Based on Federated Hermes's 13F filing for Q1 2022, filed 13 May 2022.